Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 second quarter operational and financial results after market hours on August 6, 2019.
News
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual and special meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is …
Innovative Health, the leading single-use cardiology medical device reprocessing company, today announced it has received FDA clearance for reprocessing the market-leading PENTARAY® Nav eco High-Density mapping catheter (hereinafter PentaRay), a development that represents both a technological and healthcare cost reduction milestone. The PentaRay is a key medical device in Atrial Fibrillation (AF) procedures, one of …
EY is pleased to announce the winners of the Entrepreneur Of The Year® Award in New Jersey. This group of unstoppable entrepreneurial leaders transforming our world was selected by an independent judging panel made up of previous award winners, leading CEOs, investors and other regional business leaders. The winners were unveiled at a special gala …
MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month program, featuring leading-edge device, diagnostic, and digital health technologies from around the world. These best-in-class startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, and other industry stakeholders.
Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to announce that the United States Patent and Trademark Office has issued a patent covering formulations for treating, protecting and repairing skin around the eye area. These patents support Colorescience’s multifaceted formulation and product delivery method of Total Eye® Concentrate and Total Eye® 3-in-1 Renewal Therapy …
Ristela, a plant-based product aimed at menopausal women that promises to increase sexual pleasure, was introduced on the women’s wellness website Bonafide a few weeks ago. Bonafide said that sales of Ristela in its first 10 days surpassed expectations for three months, and another menopause-focused product is planned for early next year.
Colorescience® announces the published results of their study “Beyond sun protection factor: An approach to environmental protection with novel mineral coatings in a vehicle containing a blend of skincare ingredients” in The Journal of Cosmetic Dermatology, that assessed the efficacy of their proprietary EnviroScreen™ technology – a novel, patented formulation that fights against both sun …
Kelly Williams, Founding Chair and co-CEO of PEWIN said of the awards, “PEWIN is so pleased to recognize Luminate Capital, 1315 Capital, the Teacher Retirement System of Texas and The Riverside Company, each of whom are leading by example in their support, promotion and amplification of the outstanding women investors who exist in the private …
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has completed its previously announced bought deal public offering and concurrent private placement (the “Offerings”) for total gross proceeds of C$30,579,250. The Offerings were both completed on a bought deal …